Arbor Pharma Announces Acquisition Of Xenoport At A 60% Premium

By: via Benzinga
Shares of XenoPort, Inc. (NASDAQ: XNPT), a small-cap bio-pharmaceutical company that focuses on the commercializing HORIZANT in the ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.